18590455. PROGAMMABLE POLYMERIC DRUGS simplified abstract (SONY GROUP CORPORATION)
Contents
PROGAMMABLE POLYMERIC DRUGS
Organization Name
Inventor(s)
Tracy Matray of Snohomish WA (US)
PROGAMMABLE POLYMERIC DRUGS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18590455 titled 'PROGAMMABLE POLYMERIC DRUGS
Simplified Explanation: The patent application discloses compounds with a specific structure that are useful as biologically active compounds.
Key Features and Innovation:
- The compounds have a unique structure denoted as (I).
- These compounds have demonstrated biological activity.
- The innovation lies in the discovery of these specific compounds and their potential applications.
Potential Applications: The compounds could be used in pharmaceuticals, agriculture, or other industries where biologically active compounds are needed.
Problems Solved:
- Provides a new class of compounds with potential therapeutic benefits.
- Offers a novel approach to developing biologically active compounds.
Benefits:
- Potential for the development of new drugs or agricultural products.
- Increased understanding of the structure-activity relationship in biologically active compounds.
Commercial Applications: The compounds could be developed into new pharmaceuticals, pesticides, or other products with biological activity, potentially leading to commercial success in these industries.
Questions about the Technology: 1. What specific biological activities have been demonstrated by these compounds? 2. How do these compounds compare to existing biologically active compounds in terms of efficacy and safety?
Original Abstract Submitted
Compounds useful as biologically active compounds are disclosed. The compounds have the following structure (I):
